Lactate-induced lactylation and cardiometabolic diseases: From epigenetic regulation to therapeutics

Jie Lin,Jun Ren
DOI: https://doi.org/10.1016/j.bbadis.2024.167247
2024-05-18
Biochimica et Biophysica Acta - Molecular Basis of Disease
Abstract:Cardiometabolic diseases (CMDs) denote a cadre of chronic and devastating cardiovascular anomalies routed from metabolic derangements including obesity, type 2 diabetes mellitus, and hypertension. Recent studies have demonstrated the association between histone lactylation, a unique form of post-translational modification, and pathogenesis of CMDs, apparently through epigenetic mechanisms. Lactylation has been indicated to regulate key aspects of metabolism, inflammation, and cardiovascular function in the realm of CMDs in a cellular and tissue-specific manner. A better understanding of the molecular, cellular and physiological domains of lactylation in the etiology of CMDs is expected to offer new insights into etiopathogenesis, hazardous factor control and therapeutic development for these challenging ailments.
What problem does this paper attempt to address?